XML 32 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2017   18,458        
Balance at the beginning of the period at Dec. 31, 2017 $ 399.9 $ 0.2 $ (65.8) $ 323.9 $ 235.7 $ (94.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 16.2       16.2  
Other comprehensive income, after income tax benefit 7.3         7.3
Dividends declared (7.0)       (7.0)  
Shares purchased (Note 9) (5.3)   (5.3)      
Stock options exercised (in shares)   20        
Stock options exercised 0.1     0.1    
Stock-based compensation 1.8     1.8    
Ending balance (in shares) at Mar. 31, 2018   18,478        
Balance at the end of the period at Mar. 31, 2018 412.2 $ 0.2 (71.1) 325.8 243.8 (86.5)
Beginning balance (in shares) at Dec. 31, 2017   18,458        
Balance at the beginning of the period at Dec. 31, 2017 399.9 $ 0.2 (65.8) 323.9 235.7 (94.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 23.5          
Other comprehensive income, after income tax benefit (0.7)          
Ending balance (in shares) at Sep. 30, 2018   18,533        
Balance at the end of the period at Sep. 30, 2018 399.1 $ 0.2 (72.1) 328.2 237.3 (94.5)
Beginning balance (in shares) at Mar. 31, 2018   18,478        
Balance at the beginning of the period at Mar. 31, 2018 412.2 $ 0.2 (71.1) 325.8 243.8 (86.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (4.8)       (4.8)  
Other comprehensive income, after income tax benefit (8.4)         (8.4)
Dividends declared (6.9)       (6.9)  
Shares purchased (Note 9) (1.0)   (1.0)      
Stock options exercised (in shares)   12        
Stock options exercised 0.3     0.3    
Restricted stock vesting (in shares)   8        
Restricted stock vesting (Note 9) 0.0          
Stock-based compensation 1.2     1.2    
Other/currency (0.1)     (0.1)    
Ending balance (in shares) at Jun. 30, 2018   18,498        
Balance at the end of the period at Jun. 30, 2018 392.5 $ 0.2 (72.1) 327.2 232.1 (94.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 12.1       12.1  
Other comprehensive income, after income tax benefit 0.4         0.4
Dividends declared (6.9)       (6.9)  
Stock options exercised (in shares)   35        
Stock options exercised 0.3     0.3    
Stock-based compensation 0.7     0.7    
Ending balance (in shares) at Sep. 30, 2018   18,533        
Balance at the end of the period at Sep. 30, 2018 399.1 $ 0.2 (72.1) 328.2 237.3 (94.5)
Beginning balance (in shares) at Dec. 31, 2018   18,597        
Balance at the beginning of the period at Dec. 31, 2018 390.2 $ 0.2 (76.6) 328.5 243.2 (105.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 11.8       11.8  
Other comprehensive income, after income tax benefit (1.7)         (1.7)
Dividends declared (7.6)       (7.6)  
Shares purchased (Note 9) (0.3)   (0.3)      
Stock options exercised (in shares)   9        
Stock options exercised 0.0          
Restricted stock vesting (in shares)   3        
Restricted stock vesting (Note 9) (0.1)   (0.1)      
Stock-based compensation 1.9     1.9    
Ending balance (in shares) at Mar. 31, 2019   18,609        
Balance at the end of the period at Mar. 31, 2019 394.2 $ 0.2 (77.0) 330.4 247.4 (106.8)
Beginning balance (in shares) at Dec. 31, 2018   18,597        
Balance at the beginning of the period at Dec. 31, 2018 390.2 $ 0.2 (76.6) 328.5 243.2 (105.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 39.8          
Other comprehensive income, after income tax benefit (1.3)          
Ending balance (in shares) at Sep. 30, 2019   18,635        
Balance at the end of the period at Sep. 30, 2019 405.5 $ 0.2 (81.7) 333.3 260.1 (106.4)
Beginning balance (in shares) at Mar. 31, 2019   18,609        
Balance at the beginning of the period at Mar. 31, 2019 394.2 $ 0.2 (77.0) 330.4 247.4 (106.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 13.6       13.6  
Other comprehensive income, after income tax benefit 6.2         6.2
Dividends declared (7.6)       (7.6)  
Shares purchased (Note 9) (1.6)   (1.6)      
Stock options exercised (in shares)   1        
Stock options exercised 0.0          
Restricted stock vesting (in shares)   21        
Restricted stock vesting (Note 9) 0.0          
Stock-based compensation 1.7     1.7    
Ending balance (in shares) at Jun. 30, 2019   18,631        
Balance at the end of the period at Jun. 30, 2019 406.5 $ 0.2 (78.6) 332.1 253.4 (100.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 14.4       14.4  
Other comprehensive income, after income tax benefit (5.8)         (5.8)
Dividends declared (7.7)       (7.7)  
Shares purchased (Note 9) (2.9)   (2.9)      
Stock options exercised (in shares)   2        
Stock options exercised 0.0          
Restricted stock vesting (in shares)   2        
Restricted stock vesting (Note 9) (0.2)   (0.2)      
Stock-based compensation 1.2     1.2    
Ending balance (in shares) at Sep. 30, 2019   18,635        
Balance at the end of the period at Sep. 30, 2019 $ 405.5 $ 0.2 $ (81.7) $ 333.3 $ 260.1 $ (106.4)